Last year, Nicole Friedland, NAAF President and CEO, participated in an expert steering committee, the Alopecia Areata Consensus Task Force,…
Today, the U.S. Food and Drug Administration (FDA) approved LEQSELVI™ (deuruxolitinib) for alopecia areata, marking the third FDA-approved treatment for…
NAAF awards research grants to researchers with promising proposals to learn more about alopecia areata – what is happening in…
The National Alopecia Areata Foundation applauds the announcement that the National Institutes of Health (NIH) has awarded a $6.6 million…
Members of the NAAF team represented the organization and the alopecia areata patient community at the 2024 Annual Meeting of…
Key leaders of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) met with NAAF President & CEO,…
Applications for Student Internship Awards for 2024 are now open. These awards support students (undergraduate, graduate, or medical), residents, or…
Media reports of two newly approved drugs for treating alopecia areata brought good news to many people living with the…
NAAF is pleased to announce that Zura Bio has joined the Industry Partner Program at the Bronze membership level. Zura…
Today, the U.S. Food and Drug Administration (FDA) approved LITFULO™ for severe alopecia areata, marking the second FDA-approved treatment for…
